• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析三维适形放疗治疗局部晚期非小细胞肺癌患者放射性肺炎的相关因素。

Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.

机构信息

Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, 110001, Shenyang, China.

出版信息

J Cancer Res Clin Oncol. 2010 Aug;136(8):1169-78. doi: 10.1007/s00432-010-0764-4. Epub 2010 Feb 4.

DOI:10.1007/s00432-010-0764-4
PMID:20130912
Abstract

PURPOSE

To investigate the correlation among DVH (lung dose-volume histogram) parameters, clinical factors, and grade > or = 2 radiation pneumonitis (RP) in patients with locally advanced non-small-cell lung cancer (NSCLC) treated with three-dimensional conformal radiotherapy (3D-CRT), and the differences between patients treated with 3D-CRT alone or that combined with chemotherapy on RP.

PATIENTS AND METHODS

As much as 93 patients of stage III NSCLC were treated with 3D-CRT, among which 36 were treated with chemotherapy after 3D-CRT, 57 received 3D-CRT treatment alone. The radiation dose was 62.5-65 Gy (BED = 68-72.7 Gy).

RESULTS

The morbidity of grade > or = 2 RP was 49.5%, of which grade 2 and grade 3 were 33.3 and 16.1%, respectively. The morbidity of RP in those patients treated with chemotherapy after radiotherapy was evidently higher than that of patients treated with radiotherapy alone (61.1 vs. 42.1%). According to the single factor analysis, V5-V50 and MLD of both the ipsilateral and the whole lung were all related to the occurrence of RP; comparing grade 3 with grade 2 within the same group, except V45, V50, TV20, TV30, and TMLD, other parameters also had their statistical significance (P < 0.01); comparing the non-chemotherapy-treated group with the chemotherapy-treated group, TV30 and TV35 had their statistical significance. According to logistic regression analysis; the occurrence of RP was evidently associated with the comprehensive value of DVH parameters, chemotherapy, and gender. Chemotherapy has increased the risk of RP 7.6 times. The increase of each score in the comprehensive value of DVH parameters would increase the risk of RP 22.7 times.

CONCLUSION

The comprehensive values of DVH parameters, chemotherapy, and gender have independent effects on the occurrence of RP. Most of DVH parameters were associated with the occurrence of RP. The curve shape composed of multiple points in DVH parameters was more important than any single DVH parameter.

摘要

目的

研究三维适形放疗(3D-CRT)治疗局部晚期非小细胞肺癌(NSCLC)患者的剂量-体积直方图(DVH)参数与临床因素及 2 级以上放射性肺炎(RP)的相关性,以及单纯 3D-CRT 治疗与联合化疗治疗对 RP 的影响。

方法

93 例Ⅲ期 NSCLC 患者行 3D-CRT 治疗,其中 36 例在 3D-CRT 后行化疗,57 例单纯 3D-CRT 治疗。照射剂量为 62.5-65Gy(BED=68-72.7Gy)。

结果

2 级以上 RP 的发病率为 49.5%,其中 2 级和 3 级分别为 33.3%和 16.1%。放疗后化疗患者的 RP 发病率明显高于单纯放疗患者(61.1%比 42.1%)。单因素分析显示,同侧及全肺 V5-V50、MLD 与 RP 发生相关;同一组内 3 级与 2 级比较,除 V45、V50、TV20、TV30、TMLD 外,其他参数也有统计学意义(P<0.01);非化疗组与化疗组比较,TV30、TV35 有统计学意义。Logistic 回归分析显示,RP 的发生与 DVH 参数综合值、化疗、性别显著相关,化疗使 RP 发生的风险增加 7.6 倍,DVH 参数综合值每增加 1 分,RP 发生的风险增加 22.7 倍。

结论

DVH 参数综合值、化疗、性别对 RP 的发生有独立影响,多数 DVH 参数与 RP 的发生相关,DVH 参数的曲线形态比任何单一参数都重要。

相似文献

1
Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.分析三维适形放疗治疗局部晚期非小细胞肺癌患者放射性肺炎的相关因素。
J Cancer Res Clin Oncol. 2010 Aug;136(8):1169-78. doi: 10.1007/s00432-010-0764-4. Epub 2010 Feb 4.
2
Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.剂量-体积直方图参数预测肺癌放射性肺炎的系统评价
Radiother Oncol. 2004 May;71(2):127-38. doi: 10.1016/j.radonc.2004.02.015.
3
Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non-Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters.预测局部晚期非小细胞肺癌患者胸段放疗后严重放射性肺炎:基于临床、血液学和剂量体积直方图参数的列线图的开发与验证
Clin Lung Cancer. 2025 Jul;26(5):393-406. doi: 10.1016/j.cllc.2025.02.009. Epub 2025 Feb 21.
4
Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality Collaborative.在一个大型全州质量协作项目中,局部晚期肺癌三维适形放射治疗与调强放射治疗的剂量测定与毒性比较
Int J Radiat Oncol Biol Phys. 2025 Aug 1;122(5):1248-1256. doi: 10.1016/j.ijrobp.2025.03.007. Epub 2025 Mar 10.
5
Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.局部晚期肺癌调强放疗的长期前瞻性结果:一项随机临床试验的二次分析。
JAMA Oncol. 2024 Aug 1;10(8):1111-1115. doi: 10.1001/jamaoncol.2024.1841.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.放射性肺炎的预测:62例非小细胞肺癌患者三维适形放疗后剂量体积直方图分析
Neoplasma. 2005;52(1):56-62.
8
A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.少到多还是多到少?三维适形放疗治疗肺癌患者时,基于肺部剂量体积直方图参数对肺炎风险的分析
Strahlenther Onkol. 2003 Aug;179(8):548-56. doi: 10.1007/s00066-003-1078-0.
9
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
10
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer.在一项针对不可切除的IIIA/IIIB期非小细胞肺癌同步放化疗后使用纳武利尤单抗和伊匹木单抗或单独使用纳武利尤单抗进行巩固免疫治疗的2期研究中对放射性肺炎的评估。
Int J Radiat Oncol Biol Phys. 2025 Mar 1;121(3):720-727. doi: 10.1016/j.ijrobp.2024.09.050. Epub 2024 Oct 26.

引用本文的文献

1
Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.接受表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)联合每日一次胸部放疗的非小细胞肺癌(NSCLC)患者出现有症状的放射性肺炎:预测临床和剂量-体积直方图参数的价值。
Zhongguo Fei Ai Za Zhi. 2022 Jun 20;25(6):409-419. doi: 10.3779/j.issn.1009-3419.2022.102.17.
2
Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.用于预测术后乳腺癌放疗中放射性肺损伤的剂量学因素及莱曼正常组织并发症模型分析:一项前瞻性研究
Oncotarget. 2017 May 16;8(20):33855-33863. doi: 10.18632/oncotarget.12979.
3

本文引用的文献

1
Predicting risk of radiation-induced lung injury.预测放射性肺损伤的风险。
J Thorac Oncol. 2007 Sep;2(9):864-74. doi: 10.1097/JTO.0b013e318145b2c6.
2
Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.肺部肿瘤立体定向放射治疗后出现症状性 2-5 级放射性肺炎的极高发生率。
Radiat Oncol. 2007 Jun 7;2:21. doi: 10.1186/1748-717X-2-21.
3
Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer.乳腺癌三维放疗后肺密度变化的定量评估。
A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.小鼠放射性肺损伤建模变化趋势的调查:揭示好的、坏的和不确定的方面。
Lab Invest. 2016 Sep;96(9):936-49. doi: 10.1038/labinvest.2016.76. Epub 2016 Aug 1.
4
Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.吸入性类固醇作为放疗后II级放射性肺炎有症状肺癌患者的个体化治疗——单中心经验
Radiat Oncol. 2016 Feb 2;11:12. doi: 10.1186/s13014-016-0580-3.
5
Associated factors of radiation pneumonitis induced by precise radiotherapy in 186 elderly patients with esophageal cancer.186例老年食管癌患者精确放疗所致放射性肺炎的相关因素
Int J Clin Exp Med. 2015 Sep 15;8(9):16646-51. eCollection 2015.
6
Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis.肺癌调强放疗后低剂量照射肺组织绝对体积与放射性肺损伤的相关性:一项回顾性分析
J Radiat Res. 2015 Nov;56(6):883-8. doi: 10.1093/jrr/rrv057. Epub 2015 Oct 9.
7
Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.预测食管癌术后调强放疗和容积旋转调强放疗中急性放射性肺炎的因素。
Thorac Cancer. 2015 Jan;6(1):49-57. doi: 10.1111/1759-7714.12142. Epub 2015 Jan 7.
8
Radiation pneumonitis after radiotherapy of neck lymphoma.颈部淋巴瘤放疗后放射性肺炎
Case Rep Pulmonol. 2014;2014:614984. doi: 10.1155/2014/614984. Epub 2014 Aug 28.
9
Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy.同步或序贯放化疗治疗 III 期非小细胞肺癌患者的早期放射性肺炎的风险和预测因素。
Radiat Oncol. 2014 Jul 30;9:172. doi: 10.1186/1748-717X-9-172.
10
Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitis.质子泵抑制剂对肺癌精确放疗所致放射性肺炎的影响。
Cell Biochem Biophys. 2014 Nov;70(2):1113-7. doi: 10.1007/s12013-014-0030-5.
Acta Oncol. 2007;46(2):187-93. doi: 10.1080/02841860600949586.
4
High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.高辐射剂量可能会降低医学上无法手术的早期非小细胞肺癌患者大肿瘤总体积的负面影响。
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):103-10. doi: 10.1016/j.ijrobp.2006.11.051. Epub 2007 Mar 23.
5
Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.胸部放疗后放射性肺炎的发生率:剂量-体积相关性
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):410-6. doi: 10.1016/j.ijrobp.2006.09.030.
6
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).对接受同步化疗和三维适形放疗(3D-CRT)的非小细胞肺癌(NSCLC)患者中与治疗相关肺炎(TRP)相关的临床和剂量学因素的分析。
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1399-407. doi: 10.1016/j.ijrobp.2006.07.1337. Epub 2006 Sep 25.
7
Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.局限期小细胞肺癌同步加速超分割放疗与化疗后的放射性肺炎:剂量体积直方图分析及与传统放化疗的比较
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1100-5. doi: 10.1016/j.ijrobp.2005.09.025. Epub 2005 Dec 20.
8
Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies.与非小细胞肺癌治疗相关的肺毒性及细胞保护策略的作用
Semin Oncol. 2005 Apr;32(2 Suppl 3):S55-9. doi: 10.1053/j.seminoncol.2005.03.010.
9
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.放射性肺炎的预测:62例非小细胞肺癌患者三维适形放疗后剂量体积直方图分析
Neoplasma. 2005;52(1):56-62.
10
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.三维适形放疗治疗肺癌后预测严重放射性肺炎的剂量-体积参数
Radiology. 2005 Apr;235(1):208-15. doi: 10.1148/radiol.2351040248. Epub 2005 Feb 9.